Step Pharma
PrivateLast Round
Grant
Feb 19, 2026
Total Funding Raised
$148.58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Step Pharma is a biotechnology company that develops proprietary small molecule therapeutics designed for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Step Pharma Comparables
Compare Step Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jabez Bio | 76% | |
| Rhizen Pharmaceuticals AG | 71% | |
| Bayer AG | 70% |
Step Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 19, 2026 | ||||
| Series C | Oct 15, 2025 | ||||
| Series C | Oct 15, 2023 | ||||
| Series B | Mar 24, 2021 | ||||
| Series A | Nov 21, 2017 | ||||
Seed | Jul 30, 2014 |
Key People
Founding team and executive leadership
Step Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Idinvest Partners | Seed, Series A |
| Inserm Transfert | Seed, Series C, Series A |
| Pontifax Venture Capital | Series B, Series A, Series C |
| Institut Imagine | Seed, Series A |
| V-Bio Ventures | Series C |
| Hadean Ventures | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Secured $2.72M in grant funding.
- Oct 28, 2025
Dr. Karen Smith appointed as the new Chief Medical Officer.
Recent news
Latest coverage and updates
- hiresJul 1, 2026
Step Ph hired Neil Gallagher as Non-Executive Director. on Jul 1st '26.
Step Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Step Pharma's valuation, stock price, and market status.
Is Step Pharma a public or private company?
Step Pharma is a private company.
What is the current stock price of Step Pharma?
Step Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Step Pharma worth (valuation)?
Valuation information for Step Pharma is not publicly available.
Can I buy Step Pharma stock?
Step Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Step Pharma's last funding round?
Step Pharma's most recent funding round was Grant on February 19, 2026.
Who are the main investors in Step Pharma?
Key investors in Step Pharma include V-Bio Ventures, Hadean Ventures, Sunstone Life Science Ventures, Kurma Partners.
Will Step Pharma IPO soon?
No public IPO plans have been announced for Step Pharma.
How can I track Step Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Step Pharma's secondary market activity and sign up for updates.